

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.16872784 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 6.04894357 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 6.04894357 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.04894357 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.04894357 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.04894357 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 6.04894357 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.44663813 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.44663813 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.36214386 |
| 11 | response to peptidoglycan (GO:0032494) | 5.19404814 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.14277302 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 5.10807527 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.05297033 |
| 15 | detection of other organism (GO:0098543) | 4.97974322 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.82059774 |
| 17 | cellular extravasation (GO:0045123) | 4.75870530 |
| 18 | detection of bacterium (GO:0016045) | 4.59264891 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.59054030 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.57362430 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.46670089 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45757893 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44149335 |
| 24 | microglial cell activation (GO:0001774) | 4.37991478 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34583636 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.26438283 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.16855966 |
| 28 | response to host immune response (GO:0052572) | 4.15691238 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.15691238 |
| 30 | detection of biotic stimulus (GO:0009595) | 4.10007805 |
| 31 | macrophage activation (GO:0042116) | 4.06548055 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.86288142 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.82698029 |
| 34 | response to host (GO:0075136) | 3.82698029 |
| 35 | response to host defenses (GO:0052200) | 3.82698029 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.78495257 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.76035456 |
| 38 | neutrophil activation (GO:0042119) | 3.75001853 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.71967351 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66382751 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.64174581 |
| 42 | respiratory burst (GO:0045730) | 3.60831239 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.60459072 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59698616 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.56454959 |
| 46 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.55847035 |
| 47 | granulocyte activation (GO:0036230) | 3.53941910 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.48628379 |
| 49 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.48553217 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45490875 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.44509011 |
| 52 | positive regulation of mast cell degranulation (GO:0043306) | 3.44343372 |
| 53 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44343372 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.42724977 |
| 55 | leukocyte aggregation (GO:0070486) | 3.42392027 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.41743108 |
| 57 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.37574834 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.34690576 |
| 59 | T-helper 1 type immune response (GO:0042088) | 3.31341428 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31300514 |
| 61 | B cell mediated immunity (GO:0019724) | 3.27384047 |
| 62 | neutrophil mediated immunity (GO:0002446) | 3.27356556 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.26480843 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 3.25203804 |
| 65 | defense response to protozoan (GO:0042832) | 3.24626753 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.24226479 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.24226479 |
| 68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23169129 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22347207 |
| 70 | response to type I interferon (GO:0034340) | 3.22334046 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.21068432 |
| 72 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20975158 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.20627191 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.15938530 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 3.13801653 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.13498861 |
| 77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.13352228 |
| 78 | germinal center formation (GO:0002467) | 3.12001022 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.09330061 |
| 80 | T cell migration (GO:0072678) | 3.06431343 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05177662 |
| 82 | positive regulation of type 2 immune response (GO:0002830) | 3.04604137 |
| 83 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03967879 |
| 84 | positive thymic T cell selection (GO:0045059) | 3.03912924 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 3.03508810 |
| 86 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98226097 |
| 87 | regulation of B cell differentiation (GO:0045577) | 2.94895498 |
| 88 | response to protozoan (GO:0001562) | 2.94776542 |
| 89 | regulation of antigen processing and presentation (GO:0002577) | 2.94136613 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93004062 |
| 91 | myeloid leukocyte mediated immunity (GO:0002444) | 2.90089172 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.89590245 |
| 93 | myeloid leukocyte activation (GO:0002274) | 2.85778744 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.82757099 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79980538 |
| 96 | response to interleukin-15 (GO:0070672) | 2.79973623 |
| 97 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79582549 |
| 98 | negative T cell selection (GO:0043383) | 2.77619139 |
| 99 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77232674 |
| 100 | regulation of macrophage cytokine production (GO:0010935) | 2.76004255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.02987963 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.69605486 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.45226020 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.80186942 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68610376 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59819920 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.58439495 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.50298878 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05844404 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.97009819 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96473670 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80233332 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78400078 |
| 14 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.64969802 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61123405 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.52617923 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.51839884 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51137907 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.47484546 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40548315 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39362456 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.37763098 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35233538 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33907732 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.19349032 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16241014 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16223483 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.15735854 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.15079379 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15074718 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10491703 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.07134333 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04519492 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02204899 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00629481 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98719121 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94987804 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83707089 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.80345388 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.78607255 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76471672 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71347903 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68732951 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61555062 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58682005 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55186998 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53965921 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51159010 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49332050 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46153756 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45000297 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44307543 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42189076 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.38466470 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37194300 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36690547 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36650866 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31564623 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31412784 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27733067 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23805225 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23378749 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23128707 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22608330 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22002665 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21642108 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20101942 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19684937 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19602670 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18727747 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15785146 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12474005 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11222298 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11173882 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08386184 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07651697 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07393376 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05399274 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05328116 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04650102 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01799757 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96603676 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95863710 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95484192 |
| 85 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93098098 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92131563 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90465855 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87280373 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85727417 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83588301 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83496897 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83315727 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.78079364 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77546458 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75435157 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74821395 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73687746 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68257180 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67840452 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.66357959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.48689394 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.02324078 |
| 3 | MP0003303_peritoneal_inflammation | 3.93540809 |
| 4 | MP0003436_decreased_susceptibility_to | 3.86247578 |
| 5 | MP0002419_abnormal_innate_immunity | 3.13323463 |
| 6 | MP0005671_abnormal_response_to | 2.97206518 |
| 7 | MP0006082_CNS_inflammation | 2.95528236 |
| 8 | MP0001800_abnormal_humoral_immune | 2.86525085 |
| 9 | MP0009785_altered_susceptibility_to | 2.84741010 |
| 10 | MP0001790_abnormal_immune_system | 2.84024510 |
| 11 | MP0005387_immune_system_phenotype | 2.84024510 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.82602410 |
| 13 | MP0005025_abnormal_response_to | 2.80807335 |
| 14 | MP0000685_abnormal_immune_system | 2.67777511 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.57241827 |
| 16 | MP0002723_abnormal_immune_serum | 2.55255760 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.47972151 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.43926083 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.38215233 |
| 20 | MP0001819_abnormal_immune_cell | 2.36427663 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.35813582 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.10619392 |
| 23 | MP0003828_pulmonary_edema | 2.05831723 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.03119715 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.01579554 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.96748148 |
| 27 | MP0008260_abnormal_autophagy | 1.94774707 |
| 28 | MP0002405_respiratory_system_inflammati | 1.92631131 |
| 29 | MP0000716_abnormal_immune_system | 1.77647059 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.77366341 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.75146589 |
| 32 | MP0004947_skin_inflammation | 1.74636291 |
| 33 | MP0002398_abnormal_bone_marrow | 1.72590644 |
| 34 | MP0009278_abnormal_bone_marrow | 1.71238359 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.66456983 |
| 36 | MP0009764_decreased_sensitivity_to | 1.62996027 |
| 37 | MP0005451_abnormal_body_composition | 1.56023051 |
| 38 | MP0003690_abnormal_glial_cell | 1.53167158 |
| 39 | MP0005310_abnormal_salivary_gland | 1.49607855 |
| 40 | MP0004883_abnormal_blood_vessel | 1.49068084 |
| 41 | MP0008469_abnormal_protein_level | 1.48779921 |
| 42 | MP0003075_altered_response_to | 1.48530182 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.47889460 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.47416776 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.43664742 |
| 46 | MP0002722_abnormal_immune_system | 1.42030984 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.41805921 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.41805921 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.40755790 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.40051368 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.38486290 |
| 52 | MP0002429_abnormal_blood_cell | 1.38209947 |
| 53 | MP0000858_altered_metastatic_potential | 1.36490604 |
| 54 | MP0001853_heart_inflammation | 1.33783512 |
| 55 | MP0004510_myositis | 1.30545871 |
| 56 | MP0008004_abnormal_stomach_pH | 1.29446366 |
| 57 | MP0002132_abnormal_respiratory_system | 1.29356634 |
| 58 | MP0000343_altered_response_to | 1.25334525 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.24679458 |
| 60 | MP0005164_abnormal_response_to | 1.23095577 |
| 61 | MP0003866_abnormal_defecation | 1.19303365 |
| 62 | MP0000604_amyloidosis | 1.18121042 |
| 63 | MP0001851_eye_inflammation | 1.16640384 |
| 64 | MP0004381_abnormal_hair_follicle | 1.12952606 |
| 65 | MP0005166_decreased_susceptibility_to | 1.12808608 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.10129792 |
| 67 | MP0003448_altered_tumor_morphology | 1.08549196 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.05765188 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.02164285 |
| 70 | MP0009763_increased_sensitivity_to | 0.90762218 |
| 71 | MP0002009_preneoplasia | 0.88524649 |
| 72 | MP0003091_abnormal_cell_migration | 0.87507267 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.86414741 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.85853444 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.83583353 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.83281119 |
| 77 | MP0000249_abnormal_blood_vessel | 0.81881735 |
| 78 | MP0003045_fibrosis | 0.81655655 |
| 79 | MP0009840_abnormal_foam_cell | 0.81271257 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.80416295 |
| 81 | MP0002006_tumorigenesis | 0.79318199 |
| 82 | MP0005390_skeleton_phenotype | 0.79130906 |
| 83 | MP0001663_abnormal_digestive_system | 0.76370878 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.73038547 |
| 85 | MP0006054_spinal_hemorrhage | 0.71874620 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.69624461 |
| 87 | MP0000920_abnormal_myelination | 0.68619062 |
| 88 | MP0002933_joint_inflammation | 0.68262416 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.66157415 |
| 90 | MP0003795_abnormal_bone_structure | 0.65629286 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63382623 |
| 92 | MP0008874_decreased_physiological_sensi | 0.61510819 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.59315082 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.58884912 |
| 95 | MP0009115_abnormal_fat_cell | 0.58841127 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.58583834 |
| 97 | MP0001873_stomach_inflammation | 0.57962180 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.55353690 |
| 99 | MP0000371_diluted_coat_color | 0.55160445 |
| 100 | MP0001958_emphysema | 0.54781403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.20004866 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.02022246 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.89449689 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.40023342 |
| 5 | Myositis (HP:0100614) | 5.09475583 |
| 6 | Orchitis (HP:0100796) | 5.01786934 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.93310245 |
| 8 | Optic neuritis (HP:0100653) | 4.93310245 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.75189378 |
| 10 | Recurrent skin infections (HP:0001581) | 4.13475935 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.04130509 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.00255230 |
| 13 | Stomatitis (HP:0010280) | 3.96045612 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.84788799 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.84788799 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82634587 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.81340092 |
| 18 | Meningitis (HP:0001287) | 3.69455126 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.67079235 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.62168665 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.56353682 |
| 22 | Obstructive lung disease (HP:0006536) | 3.56353682 |
| 23 | Gingivitis (HP:0000230) | 3.54670547 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.43262822 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.43262822 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.43262822 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.39924657 |
| 28 | Vasculitis (HP:0002633) | 3.37368110 |
| 29 | Encephalitis (HP:0002383) | 3.30373464 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.30145597 |
| 31 | Hemoptysis (HP:0002105) | 3.20646384 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.12222254 |
| 33 | Urticaria (HP:0001025) | 3.07773970 |
| 34 | Pulmonary infiltrates (HP:0002113) | 3.06876491 |
| 35 | Recurrent viral infections (HP:0004429) | 3.04206202 |
| 36 | T lymphocytopenia (HP:0005403) | 2.99962210 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.91276067 |
| 38 | Increased IgE level (HP:0003212) | 2.90934262 |
| 39 | Prolonged bleeding time (HP:0003010) | 2.90528133 |
| 40 | Arterial thrombosis (HP:0004420) | 2.89512194 |
| 41 | Chest pain (HP:0100749) | 2.89410779 |
| 42 | Amyloidosis (HP:0011034) | 2.87849210 |
| 43 | Cellulitis (HP:0100658) | 2.86571024 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.85121821 |
| 45 | Colitis (HP:0002583) | 2.84228438 |
| 46 | Gingival bleeding (HP:0000225) | 2.81990258 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.78797002 |
| 48 | Epistaxis (HP:0000421) | 2.69235530 |
| 49 | Leukocytosis (HP:0001974) | 2.66505380 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.64712379 |
| 51 | Peritonitis (HP:0002586) | 2.59715972 |
| 52 | Pulmonary embolism (HP:0002204) | 2.57263913 |
| 53 | Pustule (HP:0200039) | 2.54853646 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.48000005 |
| 55 | Loss of speech (HP:0002371) | 2.43281600 |
| 56 | Gangrene (HP:0100758) | 2.42488786 |
| 57 | Episodic fever (HP:0001954) | 2.41530455 |
| 58 | Anorexia (HP:0002039) | 2.40644302 |
| 59 | Osteomyelitis (HP:0002754) | 2.38047910 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.34737121 |
| 61 | Abnormality of T cells (HP:0002843) | 2.29231940 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.28375312 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28089787 |
| 64 | Abnormality of the peritoneum (HP:0002585) | 2.26310986 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.26235159 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23769038 |
| 67 | Abnormality of the endocardium (HP:0004306) | 2.21615476 |
| 68 | Hematochezia (HP:0002573) | 2.19835747 |
| 69 | Increased IgM level (HP:0003496) | 2.19442394 |
| 70 | Increased serum ferritin (HP:0003281) | 2.17086721 |
| 71 | Purpura (HP:0000979) | 2.16117995 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.14330388 |
| 73 | Disinhibition (HP:0000734) | 2.13671726 |
| 74 | Vertigo (HP:0002321) | 2.12501974 |
| 75 | Granulocytopenia (HP:0001913) | 2.08864886 |
| 76 | Agammaglobulinemia (HP:0004432) | 2.04823858 |
| 77 | Polyneuropathy (HP:0001271) | 2.02839737 |
| 78 | Viral hepatitis (HP:0006562) | 2.01808158 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.00719447 |
| 80 | Petechiae (HP:0000967) | 1.99691120 |
| 81 | Sepsis (HP:0100806) | 1.99583412 |
| 82 | Glomerulonephritis (HP:0000099) | 1.99177681 |
| 83 | Lymphopenia (HP:0001888) | 1.98603022 |
| 84 | Glomerulopathy (HP:0100820) | 1.98242049 |
| 85 | Slow saccadic eye movements (HP:0000514) | 1.97292492 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 1.96527544 |
| 87 | Premature loss of primary teeth (HP:0006323) | 1.95925431 |
| 88 | Polycythemia (HP:0001901) | 1.95468608 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 1.94992657 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94537005 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94537005 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94537005 |
| 93 | Hypochromic microcytic anemia (HP:0004840) | 1.93349063 |
| 94 | Cheilitis (HP:0100825) | 1.91380463 |
| 95 | Skin ulcer (HP:0200042) | 1.91031465 |
| 96 | Hypochromic anemia (HP:0001931) | 1.90960219 |
| 97 | Amaurosis fugax (HP:0100576) | 1.90665862 |
| 98 | Acne (HP:0001061) | 1.88639235 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87592147 |
| 100 | Mucopolysacchariduria (HP:0008155) | 1.87592147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.03543708 |
| 2 | * BLK | 3.79012706 |
| 3 | TYK2 | 3.33106259 |
| 4 | MAP4K1 | 3.05941318 |
| 5 | IRAK4 | 2.77777619 |
| 6 | CSK | 2.69423059 |
| 7 | PRPF4B | 2.61728184 |
| 8 | MAP2K3 | 2.52747897 |
| 9 | FES | 2.31658123 |
| 10 | MAP3K14 | 2.26583439 |
| 11 | ERN1 | 2.15613035 |
| 12 | ZAP70 | 2.08074495 |
| 13 | JAK3 | 1.99589625 |
| 14 | FGR | 1.91989495 |
| 15 | MAP3K13 | 1.90028018 |
| 16 | JAK1 | 1.85853477 |
| 17 | TXK | 1.79694600 |
| 18 | BTK | 1.71050122 |
| 19 | IKBKE | 1.70104620 |
| 20 | TNK2 | 1.65846575 |
| 21 | * SYK | 1.64017400 |
| 22 | MAP3K3 | 1.62914311 |
| 23 | BMPR2 | 1.62825808 |
| 24 | HCK | 1.56051201 |
| 25 | GRK6 | 1.53725559 |
| 26 | TBK1 | 1.47510844 |
| 27 | CSF1R | 1.47249953 |
| 28 | JAK2 | 1.45906594 |
| 29 | EPHB1 | 1.43921740 |
| 30 | * LYN | 1.35375501 |
| 31 | TAOK3 | 1.31235756 |
| 32 | TGFBR2 | 1.28970562 |
| 33 | MAP3K1 | 1.28114303 |
| 34 | KSR2 | 1.25135280 |
| 35 | MATK | 1.24677664 |
| 36 | TAOK1 | 1.23168565 |
| 37 | KIT | 1.22548156 |
| 38 | YES1 | 1.19873864 |
| 39 | IRAK1 | 1.17241193 |
| 40 | LCK | 1.14042434 |
| 41 | TEC | 1.10859198 |
| 42 | IRAK2 | 1.07790575 |
| 43 | IKBKB | 1.07015438 |
| 44 | CDC42BPA | 1.06578621 |
| 45 | ITK | 1.03995737 |
| 46 | MARK2 | 0.99226303 |
| 47 | MAP3K11 | 0.97273041 |
| 48 | PIK3CG | 0.93654266 |
| 49 | MARK3 | 0.93484629 |
| 50 | GRK7 | 0.91771985 |
| 51 | STK10 | 0.91540673 |
| 52 | PDK1 | 0.88040821 |
| 53 | MAP3K2 | 0.87000854 |
| 54 | SIK3 | 0.84534763 |
| 55 | IRAK3 | 0.83290712 |
| 56 | FGFR3 | 0.81571299 |
| 57 | MAPK7 | 0.80251169 |
| 58 | MAP3K6 | 0.79736317 |
| 59 | PDPK1 | 0.77944398 |
| 60 | TRIB3 | 0.77311085 |
| 61 | TAOK2 | 0.74391570 |
| 62 | MAPK12 | 0.69987109 |
| 63 | SGK3 | 0.69205128 |
| 64 | MAP3K7 | 0.68503257 |
| 65 | FGFR4 | 0.66832166 |
| 66 | SGK2 | 0.60747936 |
| 67 | LRRK2 | 0.58210290 |
| 68 | * FYN | 0.57154315 |
| 69 | PTK6 | 0.56272675 |
| 70 | CAMK1D | 0.56059066 |
| 71 | CAMKK2 | 0.55572911 |
| 72 | MOS | 0.54095747 |
| 73 | EPHA3 | 0.54016384 |
| 74 | KSR1 | 0.53063973 |
| 75 | PTK2B | 0.49118263 |
| 76 | PRKD2 | 0.48369221 |
| 77 | HIPK2 | 0.47972194 |
| 78 | RIPK1 | 0.47567497 |
| 79 | MAP3K5 | 0.47389730 |
| 80 | CDK6 | 0.47309249 |
| 81 | PIM1 | 0.47110493 |
| 82 | SIK2 | 0.47091009 |
| 83 | CDK12 | 0.45712096 |
| 84 | PRKCQ | 0.43895984 |
| 85 | RAF1 | 0.43515182 |
| 86 | NLK | 0.41436263 |
| 87 | WNK1 | 0.40710497 |
| 88 | RET | 0.40325251 |
| 89 | RPS6KL1 | 0.39947380 |
| 90 | RPS6KC1 | 0.39947380 |
| 91 | CHUK | 0.39332557 |
| 92 | PDGFRB | 0.37788091 |
| 93 | DYRK1B | 0.36074924 |
| 94 | NEK9 | 0.35653761 |
| 95 | STK11 | 0.33711795 |
| 96 | CAMKK1 | 0.33638646 |
| 97 | ABL1 | 0.32764754 |
| 98 | MAPKAPK2 | 0.32580233 |
| 99 | RPS6KA6 | 0.32468907 |
| 100 | CAMK4 | 0.29968050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.27570249 |
| 2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.06611909 |
| 3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.75029794 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.67154160 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.64921022 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43827929 |
| 7 | * Tuberculosis_Homo sapiens_hsa05152 | 2.25511278 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.16865090 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15528194 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15230010 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13492816 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98201229 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93921967 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89818561 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.84553657 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.84051512 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80628627 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78376587 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77305384 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.75914519 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74559934 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68874565 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.66552336 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65632226 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64471618 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.57868835 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.55651615 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55061332 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52311626 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51851535 |
| 31 | * Phagosome_Homo sapiens_hsa04145 | 1.48768891 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46864713 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38008664 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35150114 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.33732921 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32135144 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32096909 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30365947 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28017384 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23685710 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.22740302 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09983615 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.09723733 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.06345620 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98408664 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.97307638 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96658109 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.92562325 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92167673 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87415098 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87150548 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.83138264 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83103518 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81950745 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80404520 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79050881 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77055832 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76251651 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75563814 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.75232151 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74061615 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73255137 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.72789430 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72424634 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68215078 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68087552 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66918373 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65488207 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64355120 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64071337 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63014812 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61836968 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57833993 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57625520 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55251566 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54989407 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54004547 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.52785741 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52702857 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52365576 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50276126 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49658702 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48380320 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47597898 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46282977 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.45647710 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45365865 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42973857 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42733788 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36898082 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36793961 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35935755 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35171802 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32932910 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32657373 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.32597073 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31563005 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31298880 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.30640166 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.26945307 |

